Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021

2021-11-15

BRIDGEWATER, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -Osmotica Pharmaceutical (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will present at the Jefferies London Virtual Healthcare Conference 2021 as follows: Date: Thursday, November 18, 2021 On Demand Time: 8:00AM GMT (3:00AM ET) Webcast: The presentation will be webcast on-demand and available for 30 days thereafter using the link provided above and via the Company’s website at under the “Investor & News” section. About Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a specialty pharmaceutical company focused on the development and commercialization of products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting UPNEEQ®. Osmotica has operations in the United States and Hungary. Investor and Media Relations for Osmotica Pharmaceuticals plc Lisa M. Wilson In-Site Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com

机构

RVL Pharmaceuticals Plc